These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 25052878)

  • 1. Sources of pharmaceutical opioids for non-medical use among young adults.
    Daniulaityte R; Falck R; Carlson RG
    J Psychoactive Drugs; 2014; 46(3):198-207. PubMed ID: 25052878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. "I'm not afraid of those ones just 'cause they've been prescribed": perceptions of risk among illicit users of pharmaceutical opioids.
    Daniulaityte R; Falck R; Carlson RG
    Int J Drug Policy; 2012 Sep; 23(5):374-84. PubMed ID: 22417823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Illicit use of pharmaceutical opioids among young polydrug users in Ohio.
    Daniulaityte R; Falck RS; Wang J; Carlson RG
    Addict Behav; 2009 Aug; 34(8):649-53. PubMed ID: 19398164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Latent class analysis of non-opioid dependent illegal pharmaceutical opioid users in Ohio.
    Carlson RG; Nahhas RW; Daniulaityte R; Martins SS; Li L; Falck R
    Drug Alcohol Depend; 2014 Jan; 134():259-266. PubMed ID: 24210772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Initiation into prescription opioid misuse amongst young injection drug users.
    Lankenau SE; Teti M; Silva K; Jackson Bloom J; Harocopos A; Treese M
    Int J Drug Policy; 2012 Jan; 23(1):37-44. PubMed ID: 21689917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluating the potential impact of a reformulated version of oxycodone upon tampering, non-adherence and diversion of opioids: the National Opioid Medications Abuse Deterrence (NOMAD) study protocol.
    Degenhardt L; Larance B; Bruno R; Lintzeris N; Ali R; Farrell M
    Addiction; 2015 Feb; 110(2):226-37. PubMed ID: 25358480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug sourcing and motivations among a sample of people involved in the supply of pharmaceutical drugs in Australia.
    Hulme S; Hughes CE; Nielsen S
    Int J Drug Policy; 2019 Apr; 66():38-47. PubMed ID: 30690223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Illicit use of buprenorphine in a community sample of young adult non-medical users of pharmaceutical opioids.
    Daniulaityte R; Falck R; Carlson RG
    Drug Alcohol Depend; 2012 May; 122(3):201-7. PubMed ID: 22036303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prescription Opioid Diversion Sources Among African Americans: Implications for Overdose Prevention.
    Rigg KK
    Subst Use Misuse; 2024; 59(8):1271-1274. PubMed ID: 38501692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. From oxycodone to heroin: two cases of transitioning opioid use in young Australians.
    Dertadian GC; Maher L
    Drug Alcohol Rev; 2014 Jan; 33(1):102-4. PubMed ID: 24256365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A typology of people who tamper with pharmaceutical opioids: responses to introduction of a tamper-resistant formulation of controlled-release oxycodone.
    Peacock A; Degenhardt L; Larance B; Cama E; Lintzeris N; Ali R; Bruno R
    Pharmacoepidemiol Drug Saf; 2015 Dec; 24(12):1321-33. PubMed ID: 26419615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Jurisdictional differences in opioid use, other licit and illicit drug use, and harms associated with substance use among people who tamper with pharmaceutical opioids.
    Peacock A; Bruno R; Cama E; Kihas I; Larance B; Lintzeris N; Hordern A; White N; Ali R; Degenhardt L
    Drug Alcohol Rev; 2015 Nov; 34(6):611-22. PubMed ID: 26084592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. OxyContin® as currency: OxyContin® use and increased social capital among rural Appalachian drug users.
    Jonas AB; Young AM; Oser CB; Leukefeld CG; Havens JR
    Soc Sci Med; 2012 May; 74(10):1602-9. PubMed ID: 22465379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Collaboration or coercion? Partnering to divert prescription opioid medications.
    Green TC; Bowman SE; Ray M; Zaller N; Heimer R; Case P
    J Urban Health; 2013 Aug; 90(4):758-67. PubMed ID: 23371052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relative preferences in the abuse of immediate-release versus extended-release opioids in a sample of treatment-seeking opioid abusers.
    Cicero TJ; Ellis MS; Kasper ZA
    Pharmacoepidemiol Drug Saf; 2017 Jan; 26(1):56-62. PubMed ID: 27594167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-analgesic effects of opioids: factors relevant to opioid abuse and abuse- deterrent formulations.
    Pergolizzi JV; Raffa RB; Pergolizzi JS; Taylor R
    Curr Pharm Des; 2012; 18(37):6109-15. PubMed ID: 22747546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Harm reduction for young people who use prescription opioids extra-medically: Obstacles and opportunities.
    Marshall BD; Green TC; Yedinak JL; Hadland SE
    Int J Drug Policy; 2016 May; 31():25-31. PubMed ID: 26919826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of prescription opioids with abuse-deterrent technology to address opioid abuse.
    Michna E; Kirson NY; Shei A; Birnbaum HG; Ben-Joseph R
    Curr Med Res Opin; 2014 Aug; 30(8):1589-98. PubMed ID: 24738694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Understanding the demand side of the prescription opioid epidemic: Does the initial source of opioids matter?
    Cicero TJ; Ellis MS
    Drug Alcohol Depend; 2017 Apr; 173 Suppl 1():S4-S10. PubMed ID: 28363319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-prescribed use of substitution medication among German drug users--prevalence, motives and availability.
    Schmidt CS; Schulte B; Wickert C; Thane K; Kuhn S; Verthein U; Reimer J
    Int J Drug Policy; 2013 Nov; 24(6):e111-4. PubMed ID: 23726899
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.